Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study

被引:10
作者
Narejos Perez, Silvia [1 ]
Ramon Torrell, Josep Maria [2 ]
Poder, Airi [3 ]
Leroux-Roels, Isabel [4 ]
Perez-Breva, Lina [5 ]
Steenackers, Katie [6 ]
Vandermeulen, Corinne [7 ]
Meisalu, Sandra [8 ]
McNally, Damien [9 ]
Bowen, Jordan S. T. [10 ]
Heer, Amardeep [11 ]
Beltran Martinez, Adrian [12 ]
Helman, Laura L. [13 ]
Arora, Amit [14 ]
Feldman, Robert G. [15 ]
Patel, Rajul [16 ]
Shah, Amit [17 ]
Devadiga, Raghavendra [18 ]
Damaso, Silvia [19 ]
Matthews, Sean [19 ]
Pircon, Jean-Yves [19 ]
Luyts, Dominique [19 ]
机构
[1] CAP Centelles, Barcelona, Spain
[2] Hosp Bellvitge Princeps Espanya, Barcelona, Spain
[3] Clin Res Ctr, Tartu, Estonia
[4] Ghent Univ Hosp, Ctr Vaccinol, Ghent, Belgium
[5] Fdn Fomento Invest Sanitaria & Biomed, Valencia, Spain
[6] Univ Antwerp, Ctr Evaluat Vaccinat, Antwerp, Belgium
[7] Leuven Univ, KU Leuven, Dept Publ Hlth & Primary Care, Vaccinol Ctr, Leuven, Belgium
[8] Innomed Med Ctr, Tallinn, Estonia
[9] Ormeau Hlth Ctr, Belfast, Antrim, North Ireland
[10] Oxford Univ Hosp NHS Trust, John Radcliffe Hosp, Oxford, England
[11] Lakeside Healthcare, Lakeside Surg, Corby, England
[12] Ashgate Med Practice, Chesterfield, England
[13] MOC Res, Mishawaka, IN USA
[14] Midlands Partnership NHS Fdn Trust, Haywood Community Hosp, Stoke On Trent, Staffs, England
[15] Sr Clin Trials, Laguna Hills, CA USA
[16] Solent NHS Trust, Royal South Hants Hosp, Clin Res Off, Southampton, Hants, England
[17] Piedmont Res Partners LLC, Ft Mill, SC USA
[18] GSK, Bangalore, Karnataka, India
[19] GSK, Wavre, Belgium
来源
OPEN FORUM INFECTIOUS DISEASES | 2023年 / 10卷 / 04期
关键词
care facilities; community-dwelling; incidence; burden of disease; older adults; respiratory syncytial virus infection; INFECTION;
D O I
10.1093/ofid/ofad111
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lay Summary Lay Summary . Respiratory syncytial virus (RSV) causes respiratory illnesses, which can lead to serious complications in older adults. We estimated how common infections due to RSV are in adults living in the community or long-term care facilities (LTCFs). For 2 years, we observed approximately 2000 adults 50 years and older in Europe and the United States. Between October 2019 and March 2020, about 2 in 100 adults in this study had RSV infections; of these, fewer than one fifth had complications and there were no hospitalizations or deaths. Other viruses were present for less than one fifth of RSV infections. Between October 2020 and June 2021, during coronavirus disease 2019 (COVID-19) restrictions, we detected RSV infection in one adult, living in a LTCF, with no complications. RSV causes respiratory disease among adults 50 years and older, and therefore programs to prevent RSV infection are needed in this age group. Background Data on respiratory syncytial virus (RSV) disease burden in adults remain scarce. We assessed the burden of confirmed RSV-acute respiratory infections (cRSV-ARIs) in community-dwelling (CD) adults and those in long-term care facilities (LTCFs). Methods In this prospective cohort study covering 2 RSV seasons (October 2019-March 2020 and October 2020-June 2021), RSV-ARIs were identified through active surveillance, in medically stable CD-adults >= 50 years (Europe) or adults >= 65 years in LTCFs (Europe and the United States). RSV infection was confirmed by polymerase chain reaction from combined nasal and throat swabs. Results Of 1981 adults enrolled, 1251 adults in CD and 664 LTCFs (season 1) and 1223 adults in CD and 494 LTCFs (season 2) were included in the analyses. During season 1, overall incidence rates ([IRs] cases/1000 person-years) and attack rates (ARs) for cRSV-ARIs were 37.25 (95% confidence interval [CI], 22.62-61.35) and 1.84% in adults in CD and 47.85 (CI, 22.58-101.4) and 2.26% in adults in LTCFs. Complications occurred for 17.4% (CD) and 13.3% (LTCFs) of cRSV-ARIs. One cRSV-ARI occurred in season 2 (IR = 2.91 [CI, 0.40-20.97]; AR = 0.20%), without complications. No cRSV-ARIs led to hospitalization or death. Viral pathogens were codetected in <= 17.4% of cRSV-ARIs. Conclusions RSV is an important cause of disease burden in adults in CD and LTCFs. Despite the observed low severity of cRSV-ARI, our results support the need for RSV prevention strategies among adults >= 50 years old. In a prospective, multi-country, cohort study covering 2 consecutive RSV seasons (Oct2019/Mar2020, Oct2020/Jun2021), the incidence rate of confirmed RSV acute respiratory infections was 37.25 and 47.85 cases/1000 person-years in older adults in community-dwelling and long-term care facilities, respectively.
引用
收藏
页数:10
相关论文
共 41 条
  • [1] Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults
    Ackerson, Bradley
    Tseng, Hung Fu
    Sy, Lina S.
    Solano, Zendi
    Slezak, Jeff
    Luo, Yi
    Fischetti, Christine A.
    Shinde, Vivek
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 69 (02) : 197 - 203
  • [2] Morbidity and mortality of respiratory syncytial virus infection in hospitalized adults: Comparison with seasonal influenza
    Atamna, Alaa
    Babich, Tanya
    Froimovici, Dafi
    Yahav, Dafna
    Sorek, Nadav
    Ben-Zvi, Haim
    Leibovici, Leonard
    Bishara, Jihad
    Avni, Tomer
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 103 : 489 - 493
  • [3] Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old
    Belongia, Edward A.
    King, Jennifer P.
    Kieke, Burney A.
    Pluta, Joanna
    Al-Hilli, Ali
    Meece, Jennifer K.
    Shinde, Vivek
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (12):
  • [4] Respiratory Syncytial Virus Infection in Older Adults: An Under-Recognized Problem
    Branche, Angela R.
    Falsey, Ann R.
    [J]. DRUGS & AGING, 2015, 32 (04) : 261 - 269
  • [5] The burden of respiratory infections among older adults in long-term care: a systematic review
    Childs, Arielle
    Zullo, Andrew R.
    Joyce, Nina R.
    McConeghy, Kevin W.
    van Aalst, Robertus
    Moyo, Patience
    Bosco, Elliott
    Mor, Vincent
    Gravenstein, Stefan
    [J]. BMC GERIATRICS, 2019, 19 (01)
  • [6] AN ANTIGENIC ANALYSIS OF RESPIRATORY SYNCYTIAL VIRUS ISOLATES BY A PLAQUE REDUCTION NEUTRALIZATION TEST
    COATES, HV
    ALLING, DW
    CHANOCK, RM
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1966, 83 (02) : 299 - &
  • [7] Impact of respiratory syncytial virus disease on quality of life in adults aged >= 50 years: A qualitative patient experience cross-sectional study
    Curran, Desmond
    Cabrera, Eliazar Sabater
    Bracke, Benjamin
    Raymond, Kimberly
    Foster, April
    Umanzor, Cindy
    Goulet, Philibert
    Powers, John H. I. I. I. I. I. I.
    [J]. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (03) : 462 - 473
  • [8] Priorities for developing respiratory syncytial virus vaccines in different target populations
    Drysdale, Simon B.
    Barr, Rachael S.
    Rollier, Christine S.
    Green, Christopher A.
    Pollard, Andrew J.
    Sande, Charles J.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (535)
  • [9] A combination of naso- and oropharyngeal swabs improves the diagnostic yield of respiratory viruses in adult emergency department patients
    Ek, Peter
    Bottiger, Blenda
    Dahlman, Disa
    Hansen, Karin B.
    Nyman, Mattias
    Nilsson, Anna C.
    [J]. INFECTIOUS DISEASES, 2019, 51 (04) : 241 - 248
  • [10] An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults
    Falloon, Judith
    Yu, Jing
    Esser, Mark T.
    Villafana, Tonya
    Yu, Li
    Dubovsky, Filip
    Takas, Therese
    Levin, Myron J.
    Falsey, Ann R.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (11) : 1362 - 1370